Role of Translationally Controlled Tumor Protein in Cancer Progression

per Chan, Tim Hon Man, Chen, Leilei, Guan, Xin-Yuan
Publicat 2012

Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma

per Chen, Leilei, Chan, Tim Hon Man, Guan, Xin-yuan
Publicat 2010

Overexpression of N-terminal kinase like gene promotes tumorigenicity of hepatocellular carcinoma by regulating cell cycle progression and cell motility

per Wang, Jian, Liu, Ming, Chen, Leilei, Chan, Tim Hon Man, Jiang, Lingxi, Yuan, Yun-Fei, Guan, Xin-Yuan
Publicat a Oncotarget (2015)

CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients

per Chen, Leilei, Chan, Tim Hon Man, Yuan, Yun-Fei, Hu, Liang, Huang, Jun, Ma, Stephanie, Wang, Jian, Dong, Sui-Sui, Tang, Kwan Ho, Xie, Dan, Li, Yan, Guan, Xin-Yuan
Publicat 2010

A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma

per Chan, Tim Hon Man, Lin, Chi Ho, Qi, Lihua, Fei, Jing, Li, Yan, Yong, Kol Jia, Liu, Ming, Song, Yangyang, Chow, Raymond Kwok Kei, Ng, Vanessa Hui En, Yuan, Yun-Fei, Tenen, Daniel G, Guan, Xin-Yuan, Chen, Leilei
Publicat 2014

Suppression of adenosine-to-inosine (A-to-I) RNA editome by death associated protein 3 (DAP3) promotes cancer progression

per Han, Jian, An, Omer, Hong, HuiQi, Chan, Tim Hon Man, Song, Yangyang, Shen, Haoqing, Tang, Sze Jing, Lin, Jaymie Siqi, Ng, Vanessa Hui En, Tay, Daryl Jin Tai, Molias, Fernando Bellido, Pitcheshwar, Priyankaa, Tan, Hui Qing, Yang, Henry, Chen, Leilei
Publicat a Sci Adv (2020)

An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer

per Qi, Lihua, Song, Yangyang, Chan, Tim Hon Man, Yang, Henry, Lin, Chi Ho, Tay, Daryl Jin Tai, Hong, HuiQi, Tang, Sze Jing, Tan, Kar Tong, Huang, Xi Xiao, Lin, Jaymie Siqi, Ng, Vanessa Hui En, Maury, Julien Jean Pierre, Tenen, Daniel G., Chen, Leilei
Publicat a Nucleic Acids Res (2017)

Recoding RNA editing of antizyme inhibitor 1 predisposes to hepatocellular carcinoma

per Chen, Leilei, Li, Yan, Lin, Chi Ho, Chan, Tim Hon Man, Chow, Raymond Kwok Kei, Song, Yangyang, Liu, Ming, Yuan, Yun-Fei, Fu, Li, Kong, Kar Lok, Qi, Lihua, Li, Yan, Zhang, Na, Tong, Amy Hin Yan, Kwong, Dora Lai-Wan, Man, Kwan, Lo, Chung Mau, Lok, Si, Tenen, Daniel G., Guan, Xin-Yuan
Publicat 2013

Targeting cancer addiction for SALL4 by shifting its transcriptome with a pharmacologic peptide

per Liu, Bee Hui, Jobichen, Chacko, Chia, C. S. Brian, Chan, Tim Hon Man, Tang, Jing Ping, Chung, Theodora X. Y., Li, Jia, Poulsen, Anders, Hung, Alvin W., Koh-Stenta, Xiaoying, Tan, Yaw Sing, Verma, Chandra S., Tan, Hong Kee, Wu, Chan-Shuo, Li, Feng, Hill, Jeffrey, Joy, Joma, Yang, Henry, Chai, Li, Sivaraman, J., Tenen, Daniel G.
Publicat a Proc Natl Acad Sci U S A (2018)

ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer

per Chan, Tim Hon Man, Qamra, Aditi, Tan, Kar Tong, Guo, Jing, Yang, Henry, Qi, Lihua, Lin, Jaymie Siqi, Ng, Vanessa Hui En, Song, Yangyang, Hong, Huiqi, Tay, Su Ting, Liu, Yujing, Lee, Jeeyun, Rha, Sun Yong, Zhu, Feng, So, Jimmy Bok Yan, Teh, Bin Tean, Yeoh, Khay Guan, Rozen, Steve, Tenen, Daniel G., Tan, Patrick, Chen, Leilei
Publicat a Gastroenterology (2016)